Is there ? http://curacaosport.net/stm-pharmaprix-25c6.pdf#masterpiece stm pharmaceuticals  Cubist, known for its Cubicin antibiotic, would gain alate-stage Trius drug that has shown promise in treating skininfections. From Optimer, Cubist will acquire the antibacterial,Dificid, which brought in sales of $19.0 million in the quarterended June.